Skip to main content

The Wistar Institute

|

Distinguished Lectures in Cancer Research Series: Orchestrating B Cell Responses to Drive Protective T Cell Immunity to Solid Tumors [Virtual Event]

Scientific Seminar Tuesday, Jan. 25, 2022 12:00 p.m. to 1:00 p.m. The Distinguished Lectures in Cancer Research series is the flagship seminar series of The Wistar Institute Cancer Center and features national and international leaders in basic an…
Read more
|

Progress Toward a Cure: A Conversation with Leading Wistar HIV Research Scientist on World AIDS Day

On the eve of World AIDS Day, we chat with trailblazing scientist Dr. Luis Montaner, Herbert Kean, M.D., Family Professor, and leader of the HIV Research Program at Wistar. On Dec. 1, tune in to hear him in person as part of the NIH World AIDS Day…
Read more
|

Congratulations to Kylie Konrath the 2021 Monica H.M. Shander Memorial Fellowship Awardee

This prestigious award was established in 1981 in memory of former Wistar predoctoral trainee Monica H.M. Shander and is given annually to a predoctoral trainee who displays excellence in scholastics as well as aptitude and diligence in the labora…
Read more
|

Fox Chase Cancer Center, The Wistar Institute Announce Opening of Phase 1 Clinical Trial of Anticancer Drug Candidate

PHILADELPHIA — (Dec. 2, 2021) — Fox Chase Cancer Center has opened an investigator-initiated, phase 1 clinical trial to evaluate the safety and efficacy of gamitrinib in patients with advanced cancer. Gamitrinib is a first-in-class, mitochondrial-…
Read more
|

Wistar Scientists Identify Genes Critical to Protecting Ovarian Cancer from the Immune System

PHILADELPHIA — (Nov. 30, 2021) — Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy. However, some cancers respond poorly to immunotherapy, and ovarian cance…
Read more
|

Wistar Study Identifies Two Genes That Protect Ovarian Cancer from the Immune System

Discovery could make immunotherapy more effective for ovarian and other cancers. Immunotherapy has shown significant benefits in treating many cancers, especially when combined with chemotherapy. But many cancers are resistant to immunotherapy. Ov…
Read more
|

The Wistar Institute Receives $4 Million in Funding From the Commonwealth of Pennsylvania to Advance COVID-19 Research, Address COVID-19 Risk on Vulnerable Populations, and Assess Pandemic Preparedness

PHILADELPHIA — (Nov. 23, 2021) — The Commonwealth of Pennsylvania has granted The Wistar Institute $4 million to fund COVID-19 research focused on understanding the impact of COVID-19 on certain at-risk populations and supporting the commonwealth’…
Read more
|

Wistar Scientists Discover Sugar Molecule on HIV-infected Cell That Plays a Role in Evading Immune System

All cells have an outer layer of sugar molecules – like the candy coating on an M&M. Now a new study by Wistar scientists shows how these sugars play a key role in helping HIV cells evade the immune system. The study also shows how this mechan…
Read more
|

Wistar Champion Run for Research 2021 

Our annual run has turned out to be special in more ways than one this year. We were able to rally together for the first time since the pandemic and feel the spirited comradery among our fellow colleagues that has been greatly missed. In addition…
Read more
|

Wistar Scientists Discover Sugar Molecule on HIV-infected Cell Plays Role in Evading Immune System — They Exploit as Weakness to Make More Effective “Natural Killers” Against HIV

PHILADELPHIA — (Nov. 11, 2021) — A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, shows how key features on the surface of HIV-infec…
Read more